Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
AMG 9810: TRPV1 Antagonist Workflows for Sensory Neuron Stud
2026-07-13
AMG 9810 enables precise TRPV1 inhibition for pain and sensory neuron research, with robust workflows for calcium influx and CGRP release assays. This article distills cutting-edge insights, protocol enhancements, and troubleshooting strategies, leveraging the compound’s nanomolar potency to maximize reproducibility and translational impact.
-
DAPT (GSI-IX): Mechanistic Insight and Translational Leverag
2026-07-13
This thought-leadership article explores DAPT (GSI-IX) as a selective γ-secretase inhibitor, delving into its mechanistic basis, experimental best practices, and its strategic value for translational researchers in fields such as Alzheimer's disease, cancer, and regenerative medicine. The discussion bridges recent organoid advances and positions DAPT at the forefront of Notch pathway modulation, while offering protocol guidance and a forward-looking perspective for complex disease modeling.
-
Levofloxacin: Synthetic Fluoroquinolone Antibiotic in Resear
2026-07-12
Levofloxacin stands out as a synthetic fluoroquinolone antibiotic, uniquely enabling high-precision assays in bacterial DNA replication and bone-cartilage metabolism. This guide translates complex bench protocols into actionable workflows, data-driven troubleshooting, and cross-domain applications for APExBIO’s Levofloxacin, maximizing both experimental reliability and scientific insight.
-
Viral Regulation of Necroptosis: Targeting RIPK3 to Modulate
2026-07-10
Liu et al. identify a class of viral proteins (vIRD) in orthopoxviruses that promote the proteasomal degradation of the necroptosis kinase RIPK3, suppressing inflammatory cell death and modulating virus-induced inflammation. This mechanistic insight advances understanding of viral immune evasion and provides a framework for studying regulated cell death in infection models.
-
SVA 3A/2B Proteins and DDX23: Caspase Pathways in Viral Evas
2026-07-09
This study reveals how Senecavirus A (SVA) proteins 3A and 2B manipulate host DDX23 through distinct caspase-dependent apoptotic pathways, unraveling viral evasion tactics and host restriction mechanisms. The findings identify key amino acid residues and caspase-2, -3, and -6 signaling as pivotal, providing a mechanistic foundation for targeted antiviral strategies and future vaccine design.
-
Optimizing Cell Assays with Caffeine (SKU N2379): Evidence &
2026-07-09
This article provides a scenario-driven, evidence-based guide for using Caffeine (SKU N2379) in cell viability and metabolic research. Addressing common laboratory challenges, it demonstrates how Caffeine’s validated properties and reproducibility support reliable outcomes across cancer research and metabolic assay workflows. Explore protocol insights, comparative data, and practical recommendations for integrating this compound into advanced experimental designs.
-
Trolox in Antioxidant Assays: Protocols, Packaging, and Pitf
2026-07-08
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) empowers high-precision oxidative injury research as both a standard and mechanistic probe. Learn how APExBIO's Trolox enables robust antioxidant workflows, supports innovative bioactive packaging, and drives reliable results in complex in vitro systems.
-
GI 254023X: Precision ADAM10 Inhibitor for Applied Research
2026-07-08
GI 254023X enables targeted dissection of ADAM10-mediated signaling, offering high selectivity for advanced studies in apoptosis, vascular integrity, and endothelial protection. Its robust performance in both cellular and animal models sets a new benchmark for research demanding precise modulation of metalloprotease activity.
-
GRE Combination Inhibits Melanogenesis via CREB/MITF Pathway
2026-07-07
This study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) potently suppresses melanin synthesis, oxidative stress, and inflammation in vitro. By targeting the CREB/MITF signaling axis, the research provides mechanistic insight and a foundation for safer, more effective interventions in pigmentation regulation research.
-
ER Stress-Driven Prometastatic States: Insights into Metasta
2026-07-07
Conod et al. (2022) demonstrate that tumor cells surviving near-lethal insults can enter stable prometastatic states, driven by ER stress, transcriptional reprogramming, and cytokine-mediated paracrine signaling. This work clarifies early metastatic mechanisms and highlights actionable targets for metastasis prevention and intervention.
-
Bestatin Stimulates Endothelial Invasion in Fibrin Matrices
2026-07-06
This study reveals that Bestatin (Ubenimex), traditionally viewed as an anti-angiogenic agent, unexpectedly enhances microvascular endothelial cell invasion and tube formation in fibrin matrices. The findings challenge established assumptions about aminopeptidase inhibition and angiogenesis, prompting a re-examination of Bestatin's mechanistic roles in cancer research.
-
CPSIT_0844 Drives IL-6/IL-8 via TLR2/4–NF-κB in Monocyte Inf
2026-07-06
This study elucidates how the C. psittaci inclusion membrane protein CPSIT_0844 activates human monocyte inflammatory responses, specifically increasing IL-6 and IL-8 via TLR2/TLR4-mediated signaling. The findings clarify molecular mechanisms behind severe inflammatory pathology in psittacosis and provide a framework for dissecting host–pathogen signaling pathways.
-
Bay 11-7821 (BAY 11-7082): Optimizing Inflammatory Signaling
2026-07-05
Bay 11-7821 (BAY 11-7082) is redefining inflammatory signaling pathway research and apoptosis regulation studies, enabling precise, dose-dependent modulation of NF-κB and related cellular responses. This guide delivers actionable workflow enhancements, troubleshooting solutions, and integrative insights for maximizing assay reliability in cancer and immunology contexts.
-
KG-501: Precision Workflow for Transcriptional Coactivator D
2026-07-04
KG-501 enables targeted CREB and Myb pathway interrogation by disrupting transcriptional coactivator interactions, offering a robust tool for epigenetic and oncogenic research. This article details experimental protocols, troubleshooting strategies, and practical integration with immune modulation studies in colitis-associated colorectal cancer.
-
Okadaic Acid (A4540): Protocol Guide for Phosphatase Inhibit
2026-07-03
Okadaic acid is a potent, marine-derived protein phosphatase 1 and 2A inhibitor used to dissect phosphorylation-dependent cellular mechanisms, particularly in apoptosis and signal transduction studies. Researchers should apply this reagent where high selectivity for PP1/PP2A is required and avoid it in workflows sensitive to off-target phosphatase inhibition or solvent incompatibility.